Mathias Gehrmann
9Patents
2h-index
27Co-inventors
51Inventor score
Filing activity: Dec 12, 1997 → Oct 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7060495B2 | Fusion proteins for prodrug activation | Chemistry; Metallurgy | 23 | Expired |
| US7141380B2 | Assessment of liver fibrosis scoring with serum marker algorithms | Physics | 4 | Expired |
| US7541149B1 | Monoclonal antibody and assay for detecting PIIINP | Chemistry; Metallurgy | 1 | Expired |
| US7668661B2 | Liver disease-related methods and systems | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7273727B2 | Fusion proteins for prodrug activation | Chemistry; Metallurgy | 1 | Expired |
| US10301685B2 | Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer | Chemistry; Metallurgy | 0 | Active |
| US10577661B2 | Method for breast cancer recurrence prediction under endocrine treatment | Chemistry; Metallurgy | 0 | Active |
| US10851427B2 | Method for breast cancer recurrence prediction under endocrine treatment | Chemistry; Metallurgy | 0 | Active |
| US11913078B2 | Method for breast cancer recurrence prediction under endocrine treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.